Materials • Major Chemicals
$4.75 ▲ +0.28
(+6.26%)
MKT CAP: $738.9M • VOL: 10.60M
52W L $4 52W H $18
ROARABLE / RQD
D • 45/100
PIOTROSKI
2 / 9
FMC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.47B | $4.25B | $4.49B |
| YoY Revenue Growth % | -18.3% | -5.4% | — |
| Gross Profit | $1.28B | $1.65B | — |
| Gross Margin % | 37.0% | 38.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.63B | $506.5M | $555.6M |
| Operating Margin % | -47.0% | 11.9% | 12.4% |
| Net Income (GAAP) | -$2.24B | $341.1M | $1.32B |
| EBITDA (Normalized) | -$1.55B | $560.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | — | — | — |
| Capital Expenditures (CapEx) | $96.3M | $67.9M | — |
| Free Cash Flow (FCF) | — | — | — |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | -30.2% | 5.6% | — |
| Cash & Short-Term Equivalents | $584.5M | $357.3M | — |
| Total Debt (Short + Long Term) | $2.77B | $3.03B | — |
| Total Stockholders' Equity | $2.07B | $4.49B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FMC.